KHẢO SÁT NỒNG ĐỘ CALCI HUYẾT Ở CÁC BỆNH NHÂN LEUKEMIA TẠI MIỀN BẮC VIỆT NAM
Thông tin bài báo
Ngày nhận bài: 22/09/23                Ngày hoàn thiện: 24/10/23                Ngày đăng: 31/10/23Tóm tắt
Từ khóa
Toàn văn:
PDFTài liệu tham khảo
[1] S. Minisola, J. Pepe, S. Piemonte, and C. Cipriani, “The diagnosis and management of hypercalcaemia,” Bmj, vol. 350, 2015, Art. no. h2723.
[2] S. Jick, L. Li, V. M. Gastanaga, and A. Liede, “Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database,” Cancer epidemiology, vol. 39, no. 6, pp. 901-907, 2015.
[3] W. Goldner, “Cancer-Related Hypercalcemia,” Journal of oncology practice, vol. 12, no. 5, pp. 426-432, 2016.
[4] N. Sharma, S. Jain, S. Kumari, and S. Varma, “Hypercalcaemia with radiographic abnormalities in chronic myeloid leukaemia,” Postgraduate medical journal, vol. 74, no. 871, pp. 301-303, 1998.
[5] G. Tricot, M. A. Boogaerts, A. Broeckaert-Van Orshoven, A. Criel, A. Van Hoof, and H. Van den Berghe, “Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. A possible relation between lymphoid transformation and hypercalcemia,” Cancer, vol. 52, no. 5, pp. 841-845, 1983.
[6] C. R. Tonon, T. Silva, F. W. L. Pereira, D. A. R. Queiroz, E. L. F. Junior, D. Martins, P. S. Azevedo, M. P. Okoshi, L. A. M. Zornoff, and S. A. R. de Paiva, “A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia,” Medical science monitor: International medical Journal of experimental and clinical research, vol. 28, 2022, Art. no. e935821.
[7] Y. Dong, O. Shi, Q. Zeng, X. Lu, W. Wang, Y. Li, and Q. Wang, “Leukemia incidence trends at the global, regional, and national level between 1990 and 2017,” Experimental hematology & oncology, vol. 9, pp. 1-11, 2020.
[8] M. Amini, R. Sharma, and C. Jani, “Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020,” Archives of public health, vol. 81, no. 1, 2023, Art. no. 151.
[9] D. Toro-Tobon, S. Agosto, S. Ahmadi, M. Koops, and J. M. Bruder, “Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review,” The American journal of case reports, vol. 18, pp. 203-207, 2017.
[10] J. T. Sargent and O. P. Smith, “Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders,” British journal of haematology, vol. 149, no. 4, pp. 465-477, 2010.
[11] M. Lima, J. Coutinho, L. Bernardo, M. dos Anjos Teixeira, C. Casais, A. Canelhas, L. Queiros, A. Orfao, and B. Justica, “Philadelphia-positive T-cell acute lymphoblastic leukemia with polymyositis, migratory polyarthritis and hypercalcemia following a chronic myeloid leukemia,” Annals of hematology, vol. 81, no. 3, pp. 174-177, 2002.
[12] A. Trehan, T. Cheetham, and S. Bailey, “Hypercalcemia in acute lymphoblastic leukemia: an overview,” Journal of pediatric hematology/oncology, vol. 31, no. 6, pp. 424-427, 2009.
[13] P. J. Donovan, N. Achong, K. Griffin, J. Galligan, C. J. Pretorius, and D. S. McLeod, “PTHrP-mediated hypercalcemia: causes and survival in 138 patients,” The Journal of clinical endocrinology and metabolism, vol. 100, no. 5, pp. 2024-2029, 2015.
[14] M. Noguchi and K. Oshimi, “Extensive bone marrow necrosis and symptomatic hypercalcemia in B cell blastic transformation of chronic myeloid leukemia: report of a case and review of the literature,” Acta haematologica, vol. 118, no. 2, pp. 111-116, 2007.
[15] G. A. Clines and T. A. Guise, “Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone,” Endocrine-related cancer, vol. 12, no. 3, pp. 549-583, 2005.DOI: https://doi.org/10.34238/tnu-jst.8771
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu





